Anticoccidial Drugs Market Expected to Reach $257.8 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Anticoccidial Drugs Market," The anticoccidial drugs market was valued at $171.3 million in 2021, and is projected to reach $257.8 million  by 2031, growing at a CAGR of 4.2% from 2022 to 2031.

Coccidiosis is a hepatic or enteric disease caused by protozoan parasites of the subclass coccidia. It comprises the protozoa of the phylum Apicomplexa, family Eimeriidae. 

The Anticoccidial Drugs Market Trends such as the increase in the development of advanced anticoccidial drugs, the increase in the government initiatives for awareness about coccidiosis and its medications drive the Anticoccidial Drugs Market Growth of the anticoccidial drugs market. Moreover, the high demand of animal protein food such as meat, milk, and others, the increase in the outsourcing of the development of the anticoccidial drugs, and the development in the pharmaceutical and biotechnology industries also helps in the growth of the market.  Conversely, the rise in awareness about the new products available at affordable rates is expected to create lucrative opportunities for the Anticoccidial Drugs Industry.

The global anticoccidial drugs market is segmented based on drug class, drug action, animal type, and region. On the basis of drug class, the market is bifurcated into ionophore and synthetic drugs. On the basis of drug action, the market is classified into coccidiostatic and coccidiocidal. On the basis of animal type, the market is classified into poultry, cattle and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

On the basis of drug class, the market is classified into ionophore and synthetic drugs. The ionophore segment is projected to exhibit the Anticoccidial Drugs Market Size during the forecast period, owing to increase in the adoption of ionophore for the control of disease, increase in the prevalence of coccidiosis among the animals and increase in the awareness of control and prevention of coccidiosis.

On the basis of drug action, the market is classified into coccidiostatic and coccidiocidal. The coccidiostatic segment is anticipated to Anticoccidial Drugs Market Share, owing to upsurge in number of medicines available with coccidiostatic mechanisms of action and an increase in the number of research and development activities for the development of novel medicines. Moreover, the surge in the mode of action and the widespread use of this mode of action also help in the growth of the market.

On the basis of animal type, the market is classified into poultry, cattle and others. The cattle segment is anticipated to grow at the highest rate, owing to an increase in the number of cattle population, increase the demand for protein rich food from the cattle population. Moreover, the rise in number of pharmaceutical companies also contributes in the growth of the market.

On the basis of region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to the high prevalence rate of coccidiosis, an increase in the number of market players and a surge in the number of meat producers population in the region. 

KEY FINDINGS OF THE STUDY

• By drug class, the synthetic drugs segment accounted for major share of the anticoccidial drugs market in 2021.

• By drug action, the coccidiostatic segment is anticipated to grow with the highest CAGR throughout the forecast period.

• By animal type, the cattle segment is anticipated to grow with the highest CAGR throughout the forecast period.

• By region, North America occupied major share of the anticoccidial drugs market in 2021.